ANI Pharmaceuticals: Lalwani proposes $379K sale

The notice also lists two earlier sales under its “10b5-1 Sales” heading, each involving 5,400 shares.

Rhea-AI Filing Summary

ANI Pharmaceuticals, Inc. common stock is the subject of Nikhil Lalwani’s notice to sell 5,400 shares, with an aggregate market value of $378,864.00 and an approximate sale date of October 15, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The notice identifies the shares as acquired upon vesting of restricted stock units from February 28 through March 7, 2026.

It also lists two sales under the “10b5-1 Sales” heading: 5,400 shares on September 15, 2026, for $383,400.00 and 5,400 shares on August 25, 2026, for $401,216.22.

Key Figures

Proposed shares: 5,400 shares Aggregate market value: $378,864.00 Shares sold: 5,400 shares +3 more

6 metrics

Proposed shares 5,400 shares Approximate sale date: October 15, 2026

Aggregate market value $378,864.00 Proposed sale

Shares sold 5,400 shares September 15, 2026

Aggregate market value $383,400.00 Sale on September 15, 2026

Shares sold 5,400 shares August 25, 2026

Aggregate market value $401,216.22 Sale on August 25, 2026

Key Terms

Rule 144, restricted stock awards, restricted stock units, 10b5-1 Sales

4 terms

Rule 144 regulatory

"See the definition of “person” in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock awards financial

"Restricted Stock Awards"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

restricted stock units financial

"acquired upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for NIKHIL LALWANI"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ANIP shares did Nikhil Lalwani propose to sell?

Nikhil Lalwani reported a proposed sale of 5,400 ANI Pharmaceuticals common shares, with an aggregate market value of $378,864.00 and an approximate sale date of October 15, 2026.

What prior ANIP sales are listed in Nikhil Lalwani’s notice?

The notice lists a sale of 5,400 shares on September 15, 2026, for $383,400.00 and a sale of 5,400 shares on August 25, 2026, for $401,216.22, under the “10b5-1 Sales” heading.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 04:26 PM EDT Accepted by SEC EDGAR 10/15/2026 - 04:25 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001822629
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANI PHARMACEUTICALS, INC.
SEC File Number	001-31812
Address of Issuer	104 Carnegie Center Drive, Suite 300 Princeton NEW JERSEY 08540
Phone	(609)759-1810
Name of Person for Whose Account the Securities are To Be Sold	NIKHIL LALWANI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5400	378864.00	22959488	10/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2026	Restricted Stock Awards	Issuer			5400	02/28/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NIKHIL LALWANI 104 Carnegie Center Drive, Suite 300 Princeton NJ 08540	Common	09/15/2026	5400	383400.00
10b5-1 Sales for NIKHIL LALWANI 104 Carnegie Center Drive, Suite 300 Princeton NJ 08540	Common	08/25/2026	5400	401216.22

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 02/28/2026 through 03/07/2026.
Date of Notice	10/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Nikhil Lalwani
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)